NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus
AUTOR(ES)
Natarajan, Satheesh
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
2010
RESUMO
The development of novel therapeutic agents is essential for combating the increasing number of cases of dengue fever in endemic countries and among a large number of travelers from non-endemic countries. The dengue virus has three structural proteins and seven non-structural (NS) proteins. NS3 is a multifunctional protein with an N-terminal protease domain (NS3pro) that is responsible for proteolytic processing of the viral polyprotein, and a C-terminal region that contains an RNA triphosphatase, RNA helicase and RNA-stimulated NTPase domain that are essential for RNA replication. The serine protease domain of NS3 plays a central role in the replicative cycle of dengue virus. This review discusses the recent structural and biological studies on the NS2B-NS3 protease-helicase and considers the prospects for the development of small molecules as antiviral drugs to target this fascinating, multifunctional protein.
Documentos Relacionados
- Mutagenesis of the NS3 Protease of Dengue Virus Type 2
- Langat Flavivirus Protease NS3 Binds Caspase-8 and Induces Apoptosis
- Docking and QM/MM Studies of NS2B-NS3pro Inhibitors: a Molecular Target against the Dengue Virus
- Identification of Residues in the Dengue Virus Type 2 NS2B Cofactor That Are Critical for NS3 Protease Activation
- Genetic Screen for Monitoring Hepatitis C Virus NS3 Serine Protease Activity